fbpx Yourgene Health plc - Home
Infectious Disease
Clarigene RUO
Clarigene CE-IVD
Clarigene SARS-CoV-2 CE-IVD
Clarigene™ Feature Notes
NIPT
IONA® Nx
For Clinical Laboratories
Overview
Workflow
Clinical Performance
Benefits of the IONA® Nx NIPT Workflow
Instruments
IONA® Software
Atlas Workflow Manager
MyNIPT®
Technical Support
Quality and Regulatory
Choose IONA® Nx NIPT Workflow
Post-Market Surveillance
the IONA® test
For Clinical Laboratories
Overview
Technology
CE-IVD
Clinical Performance
Results
MyNIPT®
Application Support
FAQs
Choose IONA®
Laboratory Customer Login
For Pregnant Women
For Healthcare Professionals
Overview
Background
Clinical Performance
Results
MyNIPT®
Who can have the IONA® Test
FAQs
Responsible Screening
Choose IONA®
Resources
Contact Us
Sage™ Prenatal Screen
For Clinical Laboratories
Overview
Technology
Clinical Performance
Results
Choose Sage™
Sage QS 32plex
For Pregnant Women
Advantages of the Sage™ prenatal screen
Overview
Who can have the Sage™ test
Results
For Healthcare Professionals
Overview
Background
Who can have the Sage™ test
Clinical Performance
Results
Clinical Performance
Results
Contact Us
Reproductive Health
Cystic Fibrosis
Cystic Fibrosis Analysis
Choose CF-EU2
Male Infertility
Pregnancy Loss
Rapid Aneuploidy Analysis
QST*R Range
QST*R Feature Notes
Thrombosis Risk Panel
Precision Medicine
Elucigene DPYD
DPYD Overview
DPYD Testing Workflow
Clinical Performance
Choose Elucigene DPYD
Yourgene Flex™
DNA Size Selection / Enrichment
Ranger Technology
LightBench®
Overview
Get to the DNA you care about in NIPT
Get to the DNA you care about in Liquid Biopsy
NGS QC
LightBench® Feature Notes
Yourgene® QS250
Yourgene® SP150

Why choose CF-EU2v1?

  • CE-IVD ensures reliability
  • Clinically relevant with 80-90% coverage of the most prevalent mutations (region dependent)
  • Available population-specific bolt on panels
  • Fast turnaround time
  • Simple set up, minimal hands on time and ease of use
  • Fits comfortably into existing patient care pathways, with low  DNA input volume
  • Users can expect consistency across results – ease of interpretation
  • Data review using GeneMapper and GeneMarker software (no data transfer required)

Performance you can rely on
100% Accuracy, Repeatability & Reproducibility

 Positive Percent Agreement (PPA)Negative Percent Agreement (NPA)Overall Agreement (OA)

Accuracy

100%

100%

100%

Repeatability

100%

100%

100%

Reproducibility

100%

100%

100%

Accuracy was compared to Sanger sequencing. Accuracy of the CF-EU2v1 assay was assessed by evaluating 159 samples representing a wide variety of CFTR gene variants from 4 separate sources.